Exhibit 10.28

 

OMB No. 0990-0115

 

AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT    1. CONTRACT ID CODE     

PAGE OF PAGES
1 of 2

 

2. AMENDMENT/MODIFICATION NO.    3. EFFECTIVE DATE   
4. REQUISITION / PURCHASE REQ. NO.   5. PROJECT NO. (If applicable)

01

   9/25/2004    QXI40372     6. ISSUED BY        CODE   
7. ADMINISTERED BY (If other than Item 6)  

CODE

National Institute of Environmental Health Sciences

Acquisitions Management Branch/OM

P.O. Box 12874

Research Triangle Park, NC 27709

   OMB No. 0990-0115
DEITRA C. LUNNEY
(919) 541-0387    

 

8. NAME AND ADDRESS OF CONTRACTOR (No. street, city, county, State and ZIP Code)

 

 

Xenogen Biosciences

5 Cedar Brook Drive

Cranbury, New Jersey 08512

 

(X)   

 

9A. AMENDMENT OF SOLICITATION NO.

 

 

9B. DATED (SEE ITEM 11)

 

10A.  MODIFICATION OF CONTRACT/ORDER NO

B2  

X      

 

    273-03-C-0045 / CR300045

 

10B.  DATED (SEE ITEM 13)

CODE   FACILITY CODE       9/25/2003 11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF
SOLICITATIONS

 

The above numbered solicitation is amended as set forth in Item 14. The hour and
date specified for receipt of offers    ¨ is extended,    ¨ is not extended.

 

Offers must acknowledge receipt of this amendment prior to the hour and date
specified in the solicitation or as amended, by one of the following methods:

 

(a) By completing Item B and 15, and returning                      copies of
the amendment; (b) By acknowledging receipt of this amendment on each copy of
the offer submitted; or

 

(c) By separate letter or telegram which includes a reference to the
solicitation and amendment numbers. FAILURE OF YOUR ACKNOWLEDGMENT TO BE
RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND
DATE SPECIFIED MAY RESULT IN REJECTION OF YOUR OFFER. If by virtue of this
amendment you desire to change an offer already submitted, such change may be
made by telegram or letter, provided each telegram or letter makes reference to
the solicitation and this amendment, and is received prior to the opening hour
and date specified.

 

12. ACCOUNTING AND APPROPRIATION DATA (If required)     

EIN: 1311122130A2

   CAN: 483237_3    OC: 252Z    Current Obligation: $841,673.00     

 

13. THIS ITEM APPLIES ONLY TO MODIFICATIONS OF CONTRACTS/ORDERS,

IT MODIFIES THE CONTRACT/ORDER NO. AS DESCRIBED IN ITEM 14.

 

(X)

  

A.    THIS CHANGE ORDER IS ISSUED PURSUANT TO: (Specify authority) THE CHANGES
SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT ORDER NO. IN ITEM 10A.

    

B.    THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE
ADMINISTRATIVE CHANGES [such as changes in paying office, appropreation date,
etc.] SET FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR 41103(b).

    

C.    THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF:

    

D.    OTHER (Specify type of modification and authority)

X

   43.103(a) Bilateral Modifications: FAR 52.212-4 Contract Terms and
Conditions-Commercial Items (FEB 2002) (c) Changes

 

E. IMPORTANT: Contractor ¨ is not, x is required to sign this document and
return 2 copies to the issuing office.

 

14. DESCRIPTION OF AMENDMENT/MODIFICATION (Organized by UCF section headings,
including solicitation/contract subject matter where feasible.)

 

The Purpose of this Modification:

 

1)      To extend the base performance period by one (1) year

2)      To add funding for base performance period

3)      Summarize the impact on award and obligation amounts

  

[SEAL]

 

 

Except as provided herein, all terms and conditions of the document referenced
in item 9A or 10A, as heretofore changed, remains unchanged and in full force
and effect.

 

15A. NAME AND TITLE OF SIGNER (Type or print)    16A. NAME AND TITLE OF
CONTRACTING OFFICER (Type or print) Dr. Stephen J. McAndrew, Vice President,
Business Dev.    Antoinette Bridges, Contracting Officer

 

15B. CONTRACTOR/OFFEROR   15C. DATE SIGNED    16B. UNITED STATES OF AMERICA   
16C. DATE SIGNED /s/ Stephen J. McAndrew   7/29/04    /s/ Antoinette Bridges   
8/2/04 (Signature of person authorized to sign)        (Signature of Contracting
Officer)     

 

NSN 7540 - 01 - 152 - 8070

PREVIOUS EDITION UNUSABLE

       [SEAL]   

STANDARD FORM 30(REV. 10-83)

Prescribed by GSA

FAR (48 CFR) 53.243

 

--------------------------------------------------------------------------------

AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT   

1.      CONTRACT ID CODE

     PAGE OF PAGES             2                 2

 

CONTRACT # :

  

273-03-C-0045

  

Xenogen Biosciences

MODIFICATION #

  

01

    

 

1) Based on mutual agreement between the parties involved, the base performance
period is extended by one (1) year making the Initial Award Year period a two
year period from September 25, 2003 through September 24, 2005.

 

2) Funding in the amount of $841,673.00 is obligated to fund the initial award
year.

 

3) The parties hereby mutually agree that the full force and effect of this
modification on all provisions is as follows:

 

  a) The completion date of September 24, 2004 is hereby changed to September
24, 2005 by reason of this modification.

 

  b) The contract award amount of $1,050,008 remains in effect and is unchanged
by reason of this Modification.

 

  c) The contract obligation amount is changed from $208,335.00 to $1,050,008.00
by reason of this Modification.

 

SUMMARY FOR CLARIFICATION PURPOSES:

 

     Awarded

--------------------------------------------------------------------------------

   Obligated

--------------------------------------------------------------------------------

Prior to this Modification No. 01

   $ 1,050,008.00    $ 208,335.00

Changed per this Modification No. 01

     -0-      841,673.00     

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

  

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

Current/New Totals:

   $ 1,050,008.00    $ 1,050,008.00

 

Completion Date: September 24, 2005

 

All Other Terms and Conditions Remain Unchanged.

 

END OF MODIFICATION

 

         

NSN 7540 - 01 - 152 - 8070

  CONTINUATION PAGE   STANDARD FORM 30 (REV. 10-83)

PREVIOUS EDITION UNUSABLE

      Prescribed by GSA         FAR (48 CFR) 53.243